Sudeep Pharma, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1995, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical formulations, catering to both domestic and international markets. Specialising in a diverse range of therapeutic areas, Sudeep Pharma is renowned for its innovative approach to drug formulation and delivery systems. Their core products include a variety of generic medications, which are distinguished by their efficacy and affordability. With a commitment to quality and compliance, Sudeep Pharma has achieved significant milestones, including certifications from major regulatory bodies. This dedication has solidified its market position, making it a trusted name among healthcare professionals and patients alike.
How does Sudeep Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sudeep Pharma's score of 0 is lower than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sudeep Pharma, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Sudeep Pharma may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, Sudeep Pharma may need to consider developing and communicating its climate commitments to align with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sudeep Pharma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

